Amer Syed M.D., Facp

Chief Executive Officer at Hudson Medical Group

Amer Syed, MD, FACP has a diverse work experience. Amer started their professional career as a Student Pilot at Century Air in 2021. Amer then moved on to work as a Professional Speaker and National Speaker at Salix Pharmaceuticals from 2015 onwards. In 2019, they became the Medical Director at Lutheran Pace Life, where they oversaw the delivery of Medicare/Medicaid Capitated Program and supervised operations. Amer Syed has also worked as a National Speaker at Biohaven Pharmaceuticals, Amgen, Eli Lilly and Company, AstraZeneca, and Pfizer. Additionally, they served as the Chief Executive Officer at Hudson Medical Group from 2008. Amer has extensive experience as a speaker in various regional and national capacities, focusing on healthcare topics.

Amer Syed, MD, FACP has a diverse education history. Amer completed their Bachelor of Science in Pre-Medicine/Pre-Medical Studies at King Edward Medical College. After that, they attended Seton Hall University - ST. MICHAEL’S MEDICAL CENTER where they earned their Doctor of Medicine degree from their Internal Medicine Residency Program. Later, they pursued a Master of Business Administration (MBA) in Business Administration and Management, General from Rutgers Business School. Amer Syed has also obtained various certifications including Board Certification from the American Board of Internal Medicine, certification as a Medical Review Officer, and being a licensed Physician in the State of New York. Additionally, they became a Fellow of the American College of Physicians. While they have the eligibility for Hospice & Palliative Care Board, the specific details regarding its completion are not provided.

Links


Org chart